Scholars Central

Conference abstractPublished 28 Apr 2016

Correction of structural changes in stroke ischemic tissues in the central nervous system (CNS) by trophinotropine cerebral

Authors: Makarenko O M, Vasilieva I G, Wolfe I, Petrov P I

Taras Shevchenko National University of Kyiv, Ukraine

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Investigation of pharmacological activity of brain trophinotropic factors that formed in brain cells is very true. Receiving from female pigs after brainâÂ?Â?s hemorrhagic stroke recovery, medicine âÂ?Â?CerebralâÂ? is a peptide trophinotropines with brain protective, regulative, activative and modulative actions. Trophinotropine âÂ?Â?CerebralâÂ? was protected of the active zones of the axodendritic synapses. Destruction dendrites system of the microtubules in the pleximorph area of sensomotoric cerebrocortex is not so often registered in trophinotropine treated animals. It was shown, that âÂ?Â?CerebralâÂ? administration (0.01-0.02 mg/kg bow. imp., twice with the interval of day) to cats with experimental model of hemorrhagic stroke was accompanied with 70% decrease of mortality, reduced symptoms of the disease: recovered of limbs movements decreases of coordination disturbances and normalization of some reflexes. Under conditions of chronic emotional stress (15 days) âÂ?Â?CerebralâÂ? (0.1 mg/kg b.w., i.p., before and on the 9th day of stress exposure) prevented the decrease of rats body weight, reduced the concentration of initial and intermediate products of lipid peroxidation, normalized the activity of antioxidant enzymes (SOD and catalase) in hypothalamus and cerebro-cortex zones. âÂ?Â?CerebralâÂ? normalized spleen cytological parameters and blood neutrophils cytochemical reactions. Trophinotropine accelerates progress of structural and functional restoration of alterative neurons (activities effect), have a cytoprotective and different pharmacological properties-trigger and contrapoptotic actions in early post stroke period. This medicine was suggested for treatment of sharp periods of stroke and decompensation phases of disease have had an original medicinal form (nasal drops), which essentially, will simplify treatment patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalNeurological Disorders
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Makarenko O M”
  • BylineArticles whose byline prints “Vasilieva I G”
  • BylineArticles whose byline prints “Wolfe I”
  • BylineArticles whose byline prints “Petrov P I”